GET THE APP

Silica-Chitosan Xerogel Composite Nanospheres for Controlled Release of Lisinopril | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.

Abstract

Silica-Chitosan Xerogel Composite Nanospheres for Controlled Release of Lisinopril

Author(s): Somayeh Sadighian, Seyyed Aliasghar Arjmandi, Sahar Najaflou

Single- and double-layered nanocomposites prepared by encapsulation of lisinopril-loaded silica xerogels with the biodegradable polymer chitosan. The in vitro drug release profile from both the nanocomposites and bare nanospheres investigated. The single-layered nanocomposites (silica xerogel) showed an initial burst, followed by two sustained release stages lasting for 13 days. In comparison with the silica xerogel nanocomposites, the silica xerogel/ Chitosan nanocomposites released a reduced initial burst together with three sustained release stages. The silica xerogel/chitosan nanocomposites can provide additional advantages in the localized drug delivery applications, as compared to the silica xerogel.


Full-Text PDF

Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank
Google Scholar citation report
Citations : 25868

Der Pharma Chemica received 25868 citations as per Google Scholar report

Der Pharma Chemica peer review process verified at publons
Der Pharma Chemica- Journals on pharmaceutical chemistry